Apo CIII inhibits the activation of lipoprotein lipase by Apo CII. Reduced levels of Apo CIII result in higher fatty acid uptake fro m plasma triglycerides into adipose tissue. Thus, Apo CIII is a potential target for treatment of obesity and insulin

Numero articolo: BIOV4706-100
Unità di misura: 100 MCG
https://www.grogg-chemie.ch/web/image/product.template/925948/image_1920?unique=134b63c

240,00 CHF 240.0 CHF 240,00 CHF

240,00 CHF

Not Available For Sale

    Questa combinazione non esiste.

    Aktuelle Lieferfrist auf Anfrage

    Produttore: BIOVISION
    Numero del produttore: 4706-100
    Temperatura di stoccaggio: Freezer (-80)

    Apo CIII inhibits the activation of lipoprotein lipase by Apo CII. Reduced levels of Apo CIII result in higher fatty acid uptake fro m plasma triglycerides into adipose tissue. Thus, Apo CIII is a potential target for treatment of obesity and insulin